Table 1.
Table 1: Cohort Characteristics | |||||
---|---|---|---|---|---|
| |||||
Baseline characteristics | Total | Non-frail or prefrail (CFIa 0–0.19) | Mildly frail (CFI 0.20–0.29) | Moderately and severely frail (CFI 0.30–1) | p-value |
| |||||
Sample size, n (%) | 76,260 (100.0) | 60,639 (79.5) | 13,006 (17.1) | 2,615 (3.4) | |
Age, mean (SD) | 78.9 (7.8) | 78.3 (7.6) | 81.0 (7.7) | 82.6 (8.0) | <.0001b |
Female, n (%) | 46,141 (60.5) | 36,023 (59.4) | 8,313 (63.9) | 1,805 (69.0) | <.0001c |
Race, n (%) | |||||
Non-Hispanic White |
60,012 (78.7) | 48,270 (79.6) | 9,797 (75.3) | 1,945 (74.4) | <.0001c |
Black/ African American |
9,838 (12.9) | 7,475 (12.3) | 1,925 (14.8) | 438 (16.7) | |
Hispanic | 4,089 (5.4) | 2,954 (4.9) | 958 (7.4) | 177 (6.8) | |
Asian/Pacific Islander |
2,321 (3.0) | 1,940 (3.2) | 326 (2.5) | 55 (2.1) | |
Full/partial dual eligibility for Medicare & Medicaid, n (%) | 9,051 (11.9) | 5,824 (9.6) | 2,523 (19.4) | 704 (26.9) | <.0001c |
Part A/B state buy-in, n (%) | 8,765 (11.5) | 5,705 (9.4) | 2,409 (18.5) | 651 (24.9) | <.0001c |
Full/partial Part D limited income subsidies (LIS), n (%) | 10,552 (13.8) | 6,934 (11.4) | 2,860 (22.0) | 758 (29.0) | <.0001c |
Two or more low-income indicator (Dual eligibility, Part A/B buy-in, Part D LIS, n (%) | 9,083 (11.9) | 5,850 (9.6) | 2,529 (19.4) | 704 (26.9) | <.0001c |
Combined comorbidity score, mean (SD) | 1.1 (2.2) | 0.5 (1.5) | 2.8 (2.5) | 5.5 (3.0) | <.0001b |
Glaucoma severity, n (%) | |||||
Indeterminate | 631 (0.8) | 461 (0.8) | 137 (1.1) | 33 (1.3) | <.0001c |
Mild | 8,116 (10.6) | 6,757 (11.1) | 1,168 (9.0) | 191 (7.3) | |
Moderate | 9,106 (11.9) | 7,336 (12.1) | 1,533 (11.8) | 237 (9.1) | |
Severe | 6,822 (8.9) | 5,360 (8.8) | 1,214 (9.3) | 248 (9.5) | |
Unspecified | 3,641 (4.8) | 2,837 (4.7) | 641 (4.9) | 163 (6.2) | |
No severityrelated diagnosis code | 47,944 (62.9) | 37,888 (62.5) | 8,313 (63.9) | 1,743 (66.7) |
Claims-based frailty index
Analysis of variance (ANOVA)
Chi-squared